InflaRx Reports First Quarter 2021 Financial & Operating Results
May 12, 2021 07:30 ET
|
InflaRx N.V.
Severe COVID-19 trial enrollment reaches 178 patients; interim analysis expected in Q3 At the FDA’s suggestion, planning to request a Type A meeting to further discuss primary endpoint for the Phase...
MasterCraft Boat Holdings, Inc. Reports Record Earnings for Fiscal 2021 Third Quarter
May 12, 2021 07:30 ET
|
MasterCraft Boat Holdings, Inc.
VONORE, Tenn., May 12, 2021 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2021 third quarter ended April 4, 2021. Highlights: ...
Adamis Pharmaceuticals Schedules First Quarter 2021 Financial Results Conference Call and Business Update
May 12, 2021 07:30 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for respiratory disease,...
Thryv’s “Winning on Main Street” Podcast Aims to Help Small Businesses Rebuild Post-Pandemic
May 12, 2021 07:30 ET
|
Thryv, Inc.
Dallas, May 12, 2021 (GLOBE NEWSWIRE) -- Thryv’s “Winning on Main Street”, a weekly podcast dedicated to helping America’s small businesses modernize and automate the way they do business, has an...
Strongbridge Biopharma plc Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 12, 2021 07:30 ET
|
Strongbridge Biopharma plc
~ Reports KEVEYIS® (dichlorphenamide) First Quarter 2021 Revenue of $8.4 Million, a 25 Percent Increase Compared to $6.7 Million of Revenue During First Quarter of 2020 ~ ~ Reiterates Full-Year 2021...
Voyager Therapeutics Presents New Preclinical Data Showing Reduction of Pathological Tau with Vectorized Anti-Tau Antibody
May 12, 2021 07:30 ET
|
Voyager Therapeutics, Inc.
Findings to be presented at the 24th Annual Meeting of the American Society of Gene and Cell Therapy Data demonstrate durable expression in CNS and may represent a new single-dose therapeutic...
Aptose to Present at Upcoming Investor Conferences
May 12, 2021 07:30 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...
Minerva Neurosciences Reports First Quarter 2021 Financial Results and Business Updates
May 12, 2021 07:30 ET
|
Minerva Neurosciences, Inc
Top-line results from the open-label extension of phase 3 monotherapy trial of roluperidone for the treatment of negative symptoms of schizophrenia show continuous improvement in negative symptoms,...
Cassava Sciences Announces New $2.7 Million Research Grant Award from National Institutes of Health
May 12, 2021 07:30 ET
|
Cassava Sciences, Inc.
AUSTIN, Texas, May 12, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it has been awarded...
AzurRx BioPharma Receives Approximately $550K for its 2020 CIR (French Research Tax Credit)
May 12, 2021 07:30 ET
|
AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., May 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of...